{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:32:00Z","timestamp":1792531920693,"version":"4.5.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,7,13]],"date-time":"2025-07-13T00:00:00Z","timestamp":1752364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,13]],"date-time":"2025-07-13T00:00:00Z","timestamp":1752364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-025-02351-0","type":"journal-article","created":{"date-parts":[[2025,7,13]],"date-time":"2025-07-13T11:17:36Z","timestamp":1752405456000},"page":"1865-1875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of SGLT2i on bone health in patients with lupus nephritis: randomized double blinded placebo-controlled clinical trial"],"prefix":"10.1093","volume":"38","author":[{"given":"Mohamed Hosney","family":"Badawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab Wahba","family":"Wafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"El-Husseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourelsabah","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Abo","family":"El-Ghar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael Ibrahim","family":"Mortada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem Ahmed","family":"Nabieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Abd El-Kader","family":"Sobh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,13]]},"reference":[{"key":"2351_CR1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8094","author":"F Angum","year":"2020","unstructured":"Angum F, Khan T, Kaler J, Siddiqui L, Hussain A (2020) The prevalence of autoimmune disorders in women: a narrative review. Cureus. https:\/\/doi.org\/10.7759\/cureus.8094","journal-title":"Cureus"},{"issue":"1","key":"2351_CR2","first-page":"105","volume":"133","author":"MA Clynes","year":"2020","unstructured":"Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C (2020) The epidemiology of osteoporosis. Br Med Bull 133(1):105\u2013117","journal-title":"Br Med Bull"},{"key":"2351_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-020-00726-3","volume":"15","author":"E-L Lai","year":"2020","unstructured":"Lai E-L, Huang W-N, Chen H-H, Chen J-P, Chen D-Y, Hsieh T-Y, Hung W-T, Lai K-L, Lin C-T, Tang K-T (2020) Degraded microarchitecture by low trabecular bone score is associated with prevalent vertebral fractures in patients with systemic lupus erythematosus. Arch Osteoporos 15:1\u20137","journal-title":"Arch Osteoporos"},{"issue":"19","key":"2351_CR4","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.3390\/jcm12196202","volume":"12","author":"P Singh","year":"2023","unstructured":"Singh P, Goyal L, Mallick DC, Surani SR, Yashi K (2023) Role of sodium-glucose co-transporter 2 inhibitors in chronic kidney disease, congestive heart failure and stroke\u2014a review and clinical guide for healthcare professionals. J Clin Med 12(19):6202","journal-title":"J Clin Med"},{"key":"2351_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.918350","volume":"13","author":"B Dong","year":"2022","unstructured":"Dong B, Lv R, Wang J, Che L, Wang Z, Huai Z, Wang Y, Xu L (2022) The extraglycemic effect of SGLT-2is on mineral and bone metabolism and bone fracture. Front Endocrinol 13:918350","journal-title":"Front Endocrinol"},{"issue":"2","key":"2351_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/jdi.13340","volume":"12","author":"M Koshizaka","year":"2021","unstructured":"Koshizaka M, Ishikawa K, Ishibashi R, Maezawa Y, Sakamoto K, Uchida D, Nakamura S, Yamaga M, Yokoh H, Kobayashi A (2021) Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: subanalysis of a prospective, randomized, controlled study (PRIME-V study). J Diabetes Investig 12(2):200\u2013206","journal-title":"J Diabetes Investig"},{"issue":"10","key":"2351_CR7","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s13300-024-01634-2","volume":"15","author":"R Shigeno","year":"2024","unstructured":"Shigeno R, Horie I, Haraguchi A, Niimi R, Chiba K, Tashiro S, Kawazoe Y, Sato S, Osaki M, Kawakami A (2024) A Randomized Controlled Trial on the Effect of Luseogliflozin on Bone Microarchitecture Evaluated Using HR-pQCT in Elderly Type 2 Diabetes. Diabetes Therap 15(10):2233\u20132248","journal-title":"Diabetes Therap"},{"issue":"4","key":"2351_CR8","doi-asserted-by":"publisher","first-page":"F942","DOI":"10.1152\/ajprenal.00129.2018","volume":"315","author":"A Edwards","year":"2018","unstructured":"Edwards A, Bonny O (2018) A model of calcium transport and regulation in the proximal tubule. Am J Physiol Renal 315(4):F942\u2013F953","journal-title":"Am J Physiol Renal"},{"key":"2351_CR9","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00032.2017","author":"RT Alexander","year":"2017","unstructured":"Alexander RT, Dimke H (2017) Effect of diuretics on renal tubular transport of calcium and magnesium. Am J Physiol Renal. https:\/\/doi.org\/10.1152\/ajprenal.00032.2017","journal-title":"Am J Physiol Renal"},{"issue":"1","key":"2351_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S2213-8587(14)70227-X","volume":"3","author":"SI Taylor","year":"2015","unstructured":"Taylor SI, Blau JE, Rother KI (2015) Possible adverse effects of SGLT2 inhibitors on bone. Lancet Diabetes Endocrinol 3(1):8\u201310","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"2351_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99123","volume":"3","author":"JE Blau","year":"2018","unstructured":"Blau JE, Bauman V, Conway EM, Piaggi P, Walter MF, Wright EC, Bernstein S, Courville AB, Collins MT, Rother KI (2018) Canagliflozin triggers the FGF23\/1, 25-dihydroxyvitamin D\/PTH axis in healthy volunteers in a randomized crossover study. JCI insight 3(8):e99123","journal-title":"JCI insight"},{"issue":"1","key":"2351_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1210\/jc.2015-1860","volume":"101","author":"JP Bilezikian","year":"2016","unstructured":"Bilezikian JP, Watts NB, Usiskin K, Polidori D, Fung A, Sullivan D, Rosenthal N (2016) Evaluation of bone mineral density and bone biomarkers in patients with type 2 diabetes treated with canagliflozin. J Clin Endocrinol 101(1):44\u201351","journal-title":"J Clin Endocrinol"},{"issue":"3","key":"2351_CR13","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/dom.13103","volume":"20","author":"J Rosenstock","year":"2018","unstructured":"Rosenstock J, Frias J, P\u00e1ll D, Charbonnel B, Pascu R, Saur D, Darekar A, Huyck S, Shi H, Lauring B (2018) Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET). Diabetes Obes Metab 20(3):520\u2013529","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"2351_CR14","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/j.1463-1326.2012.01630.x","volume":"14","author":"\u00d6 Ljunggren","year":"2012","unstructured":"Ljunggren \u00d6, Bolinder J, Johansson L, Wilding J, Langkilde A, Sj\u00f6str\u00f6m C, Sugg J, Parikh S (2012) Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin. Diabetes Obes Metab 14(11):990\u2013999","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"2351_CR15","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3390\/medicina57121352","volume":"57","author":"A Masajtis-Zagajewska","year":"2021","unstructured":"Masajtis-Zagajewska A, Ho\u0142ub T, P\u0119czek K, Mak\u00f3wka A, Nowicki M (2021) Different effects of empagliflozin on markers of mineral-bone metabolism in diabetic and non-diabetic patients with stage 3 chronic kidney disease. Medicina 57(12):1352","journal-title":"Medicina"},{"issue":"2","key":"2351_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/dom.12189","volume":"16","author":"J Bolinder","year":"2014","unstructured":"Bolinder J, Ljunggren \u00d6, Johansson L, Wilding J, Langkilde A, Sj\u00f6str\u00f6m C, Sugg J, Parikh S (2014) Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. Diabetes Obes Metab 16(2):159\u2013169","journal-title":"Diabetes Obes Metab"},{"issue":"22","key":"2351_CR17","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373(22):2117\u20132128","journal-title":"N Engl J Med"},{"issue":"4","key":"2351_CR18","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/ki.2013.356","volume":"85","author":"DE Kohan","year":"2014","unstructured":"Kohan DE, Fioretto P, Tang W, List JF (2014) Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control. Kidney Int 85(4):962\u2013971","journal-title":"Kidney Int"},{"issue":"1","key":"2351_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1210\/jc.2015-3167","volume":"101","author":"NB Watts","year":"2016","unstructured":"Watts NB, Bilezikian JP, Usiskin K, Edwards R, Desai M, Law G, Meininger G (2016) Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus. J Clin Endocrinol 101(1):157\u2013166","journal-title":"J Clin Endocrinol"},{"issue":"7","key":"2351_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, De Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR (2017) Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 377(7):644\u2013657","journal-title":"N Engl J Med"},{"issue":"12","key":"2351_CR21","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00198-023-06908-2","volume":"34","author":"X Wang","year":"2023","unstructured":"Wang X, Zhang F, Zhang Y, Zhang J, Sheng Y, Wang W, Li Y (2023) Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Osteoporos Int 34(12):2013\u20132025","journal-title":"Osteoporos Int"},{"issue":"1","key":"2351_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/oby.23331","volume":"30","author":"AJY Cheong","year":"2022","unstructured":"Cheong AJY, Teo YN, Teo YH, Syn NL, Ong HT, Ting AZ, Chia AZ, Chong EY, Chan MY, Lee CH (2022) SGLT inhibitors on weight and body mass: a meta-analysis of 116 randomized-controlled trials. Obesity 30(1):117\u2013128","journal-title":"Obesity"},{"issue":"1","key":"2351_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1359\/jbmr.2001.16.1.141","volume":"16","author":"LB Jensen","year":"2001","unstructured":"Jensen LB, Kollerup G, Quaade F (2001) S\u00d8Rensen OH: Bone mineral changes in obese women during a moderate weight loss with and without calcium supplementation. J Bone Miner Res 16(1):141\u2013147","journal-title":"J Bone Miner Res"},{"issue":"22","key":"2351_CR24","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1001\/archinte.166.22.2502","volume":"166","author":"DT Villareal","year":"2006","unstructured":"Villareal DT, Fontana L, Weiss EP, Racette SB, Steger-May K, Schechtman KB, Klein S, Holloszy JO (2006) Bone mineral density response to caloric restriction\u2013induced weight loss or exercise-induced weight loss: a randomized controlled trial. Arch Intern Med 166(22):2502\u20132510","journal-title":"Arch Intern Med"},{"issue":"1","key":"2351_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1210\/jc.2006-0794","volume":"92","author":"A Janicka","year":"2007","unstructured":"Janicka A, Wren TA, Sanchez MM, Dorey F, Kim PS, Mittelman SD, Gilsanz V (2007) Fat mass is not beneficial to bone in adolescents and young adults. J Clin Endocrinol Metab 92(1):143\u2013147","journal-title":"J Clin Endocrinol Metab"},{"key":"2351_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00223-002-1019-4","volume":"73","author":"M Blum","year":"2003","unstructured":"Blum M, Harris S, Must A, Naumova E, Phillips S, Rand W, Dawson-Hughes B (2003) Leptin, body composition and bone mineral density in premenopausal women. Calcif Tissue Int 73:27\u201332","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"2351_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2215\/CJN.04530418","volume":"14","author":"MA de Jong","year":"2019","unstructured":"de Jong MA, Petrykiv SI, Laverman GD, van Herwaarden AE, de Zeeuw D, Bakker SJ, Heerspink HJ, de Borst MH (2019) Effects of dapagliflozin on circulating markers of phosphate homeostasis. Clin J Am Soc Nephrol 14(1):66\u201373","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02351-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-025-02351-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02351-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:59:12Z","timestamp":1777564752000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/7\/1865\/8457432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,13]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["2351"],"URL":"https:\/\/doi.org\/10.1007\/s40620-025-02351-0","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,13]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no financial or non-financial competing interests related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The study was conducted in accordance with the ethical standards of the Institutional Review Board (MD.21.12.574) at Mansoura University and with the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Written informed consent was obtained from all study participants before enrollment.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}